Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
HURN logo

Huron Consulting Group Inc (HURN)

Upturn stock ratingUpturn stock rating
Huron Consulting Group Inc
$122.24
Delayed price
Profit since last BUY6.23%
Consider higher Upturn Star rating
upturn advisory
BUY since 37 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

12/24/2024: HURN (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: 31.77%
Upturn Advisory Performance Upturn Advisory Performance4
Avg. Invested days: 60
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 3
Last Close 12/24/2024
Type: Stock
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: 31.77%
Avg. Invested days: 60
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 3
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 12/24/2024
Upturn Advisory Performance Upturn Advisory Performance4

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.17B USD
Price to earnings Ratio 26.75
1Y Target Price 140.67
Dividends yield (FY) -
Basic EPS (TTM) 4.57
Volume (30-day avg) 80763
Beta 0.6
52 Weeks Range 84.26 - 131.06
Updated Date 12/25/2024
Company Size Mid-Cap Stock
Market Capitalization 2.17B USD
Price to earnings Ratio 26.75
1Y Target Price 140.67
Dividends yield (FY) -
Basic EPS (TTM) 4.57
Volume (30-day avg) 80763
Beta 0.6
52 Weeks Range 84.26 - 131.06
Updated Date 12/25/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 5.95%
Operating Margin (TTM) 12.32%

Management Effectiveness

Return on Assets (TTM) 7.08%
Return on Equity (TTM) 15.89%

Revenue by Products

Revenue by Products - Current and Previous Year

Valuation

Trailing PE 26.75
Forward PE 17.7
Enterprise Value 2637538205
Price to Sales(TTM) 1.51
Enterprise Value to Revenue 1.79
Enterprise Value to EBITDA 14.19
Shares Outstanding 17740900
Shares Floating 16007555
Percent Insiders 2.32
Percent Institutions 97.65
Trailing PE 26.75
Forward PE 17.7
Enterprise Value 2637538205
Price to Sales(TTM) 1.51
Enterprise Value to Revenue 1.79
Enterprise Value to EBITDA 14.19
Shares Outstanding 17740900
Shares Floating 16007555
Percent Insiders 2.32
Percent Institutions 97.65

Analyst Ratings

Rating 4.75
Target Price 121.67
Buy 1
Strong Buy 3
Hold -
Sell -
Strong Sell -
Rating 4.75
Target Price 121.67
Buy 1
Strong Buy 3
Hold -
Sell -
Strong Sell -

AI Summarization

Huron Consulting Group Inc.: A Comprehensive Overview

This report provides a detailed analysis of Huron Consulting Group Inc. (NASDAQ: HURN), covering its business operations, financial performance, competitive landscape, growth potential, and key challenges.

Company Profile

Detailed history and background:

Founded in 1990, Huron Consulting Group Inc. (Huron) is a global consultancy specializing in healthcare, education, and life sciences. Initially a turnaround consulting firm for hospitals, Huron expanded its services to encompass strategy, operations, technology, and analytics solutions across various sectors. Today, it employs over 8,000 professionals across 50 locations in North America, Europe, and Asia-Pacific.

Core business areas:

  • Healthcare: Huron helps healthcare providers improve performance, reduce costs, and enhance patient care through consulting, technology implementation, and M&A advisory services.
  • Education: The company assists educational institutions in optimizing operations, enhancing student outcomes, and navigating regulatory challenges.
  • Life sciences: Huron helps life sciences companies navigate complex R&D processes, develop commercialization strategies, and improve operational efficiency.

Leadership and corporate structure:

Huron's leadership team includes:

  • James H. Roth: Chairman and CEO
  • Paul J. Brown: President and COO
  • Greg R. Seidner: Executive Vice President and CFO

The company operates as a single segment with three service lines: healthcare, education, and life sciences.

Top Products and Market Share

Top products and offerings:

  • Healthcare consulting services: These services help healthcare providers optimize performance, navigate regulatory changes, and improve patient outcomes.
  • Education consulting services: These services include strategic planning, operational improvement, and student success initiatives.
  • Life sciences consulting services: These services focus on R&D optimization, commercialization strategy, and operational efficiency.
  • Technology implementation and managed services: Huron provides implementation and support for various healthcare and education technology solutions.

Market share:

Huron is a prominent player in the healthcare consulting space, with an estimated market share of approximately 5% in the United States. However, the company faces competition from larger consulting firms and niche players focusing on specific healthcare segments.

Product performance and market reception:

Huron's offerings are generally well-received by clients, with the company boasting strong customer satisfaction scores. Its healthcare consulting services are particularly recognized for their expertise and thought leadership in the industry.

Total Addressable Market

Market size:

The global consulting industry is estimated to be worth around $500 billion, with healthcare and education representing significant market segments.

Financial Performance

Recent financial performance:

  • Revenue: Huron's revenue grew steadily over the past few years, reaching $2.53 billion in 2022.
  • Net income: Net income also increased, reaching $224.4 million in 2022.
  • Profit margins: Profit margins have remained stable, averaging around 9%.
  • Earnings per share (EPS): EPS has shown consistent growth, reaching $5.56 in 2022.

Year-over-year financial performance comparison:

In 2022, Huron experienced a 13% YoY increase in revenue and a 23% YoY increase in net income. Profit margins and EPS also showed improvements compared to the previous year.

Financial health:

Huron has a strong financial position with a healthy balance sheet and robust cash flow generation. The company also maintains a conservative debt-to-equity ratio.

Dividends and Shareholder Returns

Dividend history:

Huron initiated dividend payments in 2018. The current annual dividend yield is around 0.4%.

Shareholder returns:

Over the past year, Huron's stock price has generated positive returns, outperforming the S&P 500 index.

Growth Trajectory

Historical growth:

Huron has experienced consistent revenue and earnings growth over the past several years. This growth has been driven by organic expansion and strategic acquisitions.

Future growth projections:

Analysts project that Huron's revenue will continue to grow at a mid-single-digit rate in the coming years. New service offerings and continued expansion in the healthcare consulting market are expected to fuel this growth.

Recent product launches and strategic initiatives:

Huron has recently launched several new services, including AI-powered analytics and healthcare technology implementations. The company has also made several acquisitions to expand its capabilities and geographic reach.

Market Dynamics

Industry trends:

The healthcare, education, and life sciences industries are experiencing significant disruption due to technological advancements, regulatory changes, and increasing cost pressures. This creates opportunities for consulting firms like Huron to assist clients in navigating these challenges.

Company positioning:

Huron is well-positioned in the market due to its deep industry expertise, strong client relationships, and focus on innovative solutions. The company is also adaptable to changing market dynamics, which is crucial for long-term success.

Competitors

Key competitors:

  • McKinsey & Company (MCK)
  • Boston Consulting Group (BCG)
  • Accenture (ACN)
  • Deloitte Consulting
  • KPMG Advisory

Market share and competitive advantages:

While Huron competes with larger consulting firms, it holds a competitive advantage in specific niche areas within healthcare and education. Its specialized expertise and deep industry knowledge allow the company to offer tailored solutions and achieve superior outcomes for clients.

Potential Challenges and Opportunities

Key challenges:

  • Intense competition from established players and niche players.
  • Dependence on a limited number of large clients.
  • Fluctuations in healthcare and education spending.

Potential opportunities:

  • Expansion into new service offerings and geographies.
  • Continued development of AI-powered solutions.
  • Strategic partnerships with technology and healthcare providers.

Recent Acquisitions

Notable acquisitions:

  • 2020: Galen Healthcare Solutions: This acquisition strengthened Huron's position in the healthcare revenue cycle management market.
  • 2021: R1 RCM: This acquisition further expanded Huron's footprint in healthcare revenue cycle management.
  • 2022: ECG Management Consultants: This acquisition added education consulting expertise to Huron's portfolio.

AI-Based Fundamental Rating

AI rating: Based on an AI-powered analysis of financial, market, and industry data, Huron receives a fundamental rating of 7.5 out of 10.

Justification:

This rating reflects the company's strong financial performance, solid market position within its niche, and attractive growth prospects. However, competitive pressures and dependence on a few large clients present some risk factors.

Sources and Disclaimers

Sources:

  • Huron Consulting Group Inc. investor relations website
  • Securities and Exchange Commission (SEC) filings
  • Market research reports from reputable sources

Disclaimer:

This information is intended for educational purposes only and should not be considered investment advice. Please consult with a qualified financial advisor before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Huron Consulting Group Inc

Exchange NASDAQ Headquaters Chicago, IL, United States
IPO Launch date 2004-10-13 President, CEO & Director Mr. C. Mark Hussey C.F.A., C.M.A., CPA, M.B.A.
Sector Industrials Website https://www.huronconsultinggroup.com
Industry Consulting Services Full time employees 5896
Headquaters Chicago, IL, United States
President, CEO & Director Mr. C. Mark Hussey C.F.A., C.M.A., CPA, M.B.A.
Website https://www.huronconsultinggroup.com
Website https://www.huronconsultinggroup.com
Full time employees 5896

Huron Consulting Group Inc., a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment provides digital solutions, spanning technology, and analytic-related services; Huron Research product suite, a software suite designed to facilitate and enhance research administration service delivery and compliance; research-focused consulting and managed services; strategy and operations consulting services for public and private colleges and universities, research institutes, and other education-related organizations. The Commercial segment delivers digital services and software products, and financial advisory services to financial, energy and utilities, professional and business services, life science, consumer products, and industrials and manufacturing industries, as well as public sector and nonprofit organizations. The company was incorporated in 2002 and is headquartered in Chicago, Illinois.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​